Please use this identifier to cite or link to this item:
|Title:||Reduced weight gain with insulin detemir compared to NPH insulin is not explained by a reduction in hypoglycemia.|
|Citation:||DIABETES TECHNOL THER, 2008, 10 (4), pp. 273-277|
|Abstract:||Weight gain often occurs when insulin therapy is initiated. The long-acting insulin analog insulin detemir has been shown to be effective and well tolerated when used in basal-bolus regimens or as an add-on to oral antidiabetic drugs (OADs) and causes less weight gain than other insulins. The aim of this exploratory analysis was to investigate any correlations between weight change and occurrence of hypoglycemia with NPH insulin and insulin detemir.|
|Appears in Collections:||Published Articles, Dept. of Cardiovascular Sciences|
Files in This Item:
There are no files associated with this item.
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.